Prevention
Educational materials that cover preventative measures and harm reduction strategies to prevent the transmission of hepatitis C.
Materials in this section
HCV Incidence Falls as Scotland Nears WHO Target
Scotland may become one of the first countries to achieve the WHO target for HCV incidence reduction among PWID, marking a significant milestone in global hepatitis elimination efforts. More
Enhancing Hepatitis B and C Prevention Among People Who Use Drugs in Iran
Enhancing hepatitis B and C prevention among people who use drugs: Evaluating an educational intervention at a drop-in center in southwest Iran based on Protection Motivation Theory More
HCV Patients’ Insights on Blood-Borne Infection Control
In a study conducted in Egypt, researchers investigated the knowledge and practices concerning infection control precautions against blood-borne diseases among patients who have recovered from hepatitis C. More
Protecting Lives, Preventing Hepatitis C: Community-Led Responses Near the Front Line in Ukraine
In eastern Ukraine, peer-led teams deliver vital HCV prevention and treatment amid war, using community-driven approaches to save lives and pave the way for innovative new HCV prevention tools. More
Seroprevalence of Hepatitis B and Hepatitis C Viral Infections Among Refugees in Muzaffarabad, Pakistan
A study determined the seroprevalence of hepatitis B surface antigen and hepatitis C virus antibody among Kashmiri refugees in Muzaffarabad, Pakistan, and identified the key associated demographic and educational risk factors. More
Harm Reduction in Europe: Histories, Choices and Hopes
Harm Reduction Journal releases a thematic series on harm reduction, providing a comprehensive and insightful look into the journey of harm reduction across the diverse regions of Europe. More
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons
Researchers conducted a systematic review of qualitative evidence to explore the barriers and facilitators to hepatitis B and C reduction programmes in prisons from the perspectives of people in prison, custodial staff and prison healthcare staff. More
Reinfection Following Successful DAA Therapy for HCV Among People With Recent Injecting Drug Use: The SHARP-C Study
A study evaluated the incidence of HCV reinfection following successful direct acting antiviral therapy among people with recent injecting drug use. More
50 Years of Harm Reduction in Europe: High Time for Transformation
A perspective-paper argues that the adoption of harm reduction in Europe is lagging behind in important ways, leading to uneven and poor implementation of services. More
Implications of the Fragility of Opioid Agonist Treatment Continuity on Hepatitis C Re-Exposure Concerns Among People in Prison: A Qualitative Study
A study explored people’s experiences and utilisation of opioid agonist treatment as a risk reduction strategy while incarcerated. More
